Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anastasia Noel

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Biochimie|April 3, 2017
Ganglioside and related-sphingolipid profiles are altered in a cellular model of Alzheimer's diseaseAnastasia Noel, Sabrina Ingrand, Laurence Barrier
Life Sciences|June 26, 2016
The Tyr216 phosphorylated form of GSK3β contributes to tau phosphorylation at PHF-1 epitope in response to Aβ in the nucleus of SH-SY5Y cellsAnastasia Noel, Laurence Barrier, Sabrina Ingrand
Experimental Neurology|June 28, 2015
Inhibition of GSK3β by pharmacological modulation of sphingolipid metabolism occurs independently of ganglioside disturbance in a cellular model of Alzheimer's diseaseAnastasia Noel, Sabrina Ingrand, Laurence Barrier
Molecular and Cellular Neurosciences|July 5, 2016
Anti-amyloidogenic effects of glycosphingolipid synthesis inhibitors occur independently of ganglioside alterationsAnastasia Noel, Sabrina Ingrand, Laurence Barrier
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Basic Science and PathogenesisAnastasia Noel, Elodie Brison, Barry J Bedell
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Biochimie|April 3, 2017
Ganglioside and related-sphingolipid profiles are altered in a cellular model of Alzheimer's diseaseAnastasia Noel, Sabrina Ingrand, Laurence Barrier
Life Sciences|June 26, 2016
The Tyr216 phosphorylated form of GSK3β contributes to tau phosphorylation at PHF-1 epitope in response to Aβ in the nucleus of SH-SY5Y cellsAnastasia Noel, Laurence Barrier, Sabrina Ingrand
Experimental Neurology|June 28, 2015
Inhibition of GSK3β by pharmacological modulation of sphingolipid metabolism occurs independently of ganglioside disturbance in a cellular model of Alzheimer's diseaseAnastasia Noel, Sabrina Ingrand, Laurence Barrier
Molecular and Cellular Neurosciences|July 5, 2016
Anti-amyloidogenic effects of glycosphingolipid synthesis inhibitors occur independently of ganglioside alterationsAnastasia Noel, Sabrina Ingrand, Laurence Barrier
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Basic Science and PathogenesisAnastasia Noel, Elodie Brison, Barry J Bedell
Pageof 1